Catalyst Wire Dossier Catalyst Wire Dossier

Huaier Granules

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Huaier Granules, covering 2023-09-26 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients [Phase 4]

See pricing